Likely pathogenic variant in the BICD2 gene in fetus presenting with non-immune hydrops.

Natalie Chandler, Poppy Brace, Rowenna Roberts, Rhiannon Mellis

Prenatal diagnosis 2023 Jun

filter terms:

Trio exome sequencing was performed on a fetus presenting with severe hydrops fetalis at 21 + 0 weeks gestation. A novel de novo BICD2 missense variant was identified in the fetus. Pathogenic variants in the BICD2 gene are associated with lower extremity-predominant spinal muscular atrophy. The variant was initially classified as a variant of uncertain clinical significance (VUS) as at the time of analysis and initial report, pathogenic variants in the BICD2 gene specifically had not been associated with fetal hydrops and no other abnormalities had been detected. It was agreed in multidisciplinary team discussions to include the variant in the report as a VUS recommending phenotypic follow-up. The pregnancy was terminated and post-mortem findings were in keeping with a BICD2-pathogenic variant. In addition, a paper was published reporting another case with a pathogenic BICD2 variant presenting with fetal hydrops. The variant classification was then upgraded to class 4 likely pathogenic and reported as consistent with the diagnosis. This case demonstrates the importance of reporting these new gene/phenotypes in enabling others in the classification of variants, staying up-to-date with literature and following up phenotype for class 3 variants of interest. © 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.

Citation

Natalie Chandler, Poppy Brace, Rowenna Roberts, Rhiannon Mellis. Likely pathogenic variant in the BICD2 gene in fetus presenting with non-immune hydrops. Prenatal diagnosis. 2023 Jun;43(6):727-729